Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longyang Jiang

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|March 13, 2022
Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)Lin Zhao, Yan Wang, Longyang Jiang, et al.
Scientific Reports|August 13, 2025
Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in ChinaMengya Li, Qian Li, Yinhui Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2016
MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)Lin Zhao, Yan Wang, Longyang Jiang, et al.
Frontiers in Immunology|January 20, 2025
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomasHui Tang, Xuping Yang, Guoqian Li, et al.
Therapeutic Advances in Hematology|November 11, 2024
Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in ChinaMengya Li, Xiaoyan Zhong, Chengbin Zhang, et al.
Medicine|October 7, 2025
Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization studyHengli Luo, Long Han, Kai He, et al.
Translational Cancer Research|December 19, 2024
Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinomaJia Feng, Longyang Jiang, Hui Tang, et al.
Drug Delivery|August 22, 2025
Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challengesTaimin Luo, Lei Chen, Kun Tu, et al.
Frontiers in Cell and Developmental Biology|December 28, 2020
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast CancerMing Zhang, Yilin Wang, Yan Wang, et al.
Renal Failure|June 4, 2024
Association between the gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization studyWenjie Dong, Qiuyu Li, Lei Chen, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|March 13, 2022
Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)Lin Zhao, Yan Wang, Longyang Jiang, et al.
Scientific Reports|August 13, 2025
Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in ChinaMengya Li, Qian Li, Yinhui Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 5, 2016
MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)Lin Zhao, Yan Wang, Longyang Jiang, et al.
Frontiers in Immunology|January 20, 2025
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomasHui Tang, Xuping Yang, Guoqian Li, et al.
Therapeutic Advances in Hematology|November 11, 2024
Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in ChinaMengya Li, Xiaoyan Zhong, Chengbin Zhang, et al.
Medicine|October 7, 2025
Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization studyHengli Luo, Long Han, Kai He, et al.
Translational Cancer Research|December 19, 2024
Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinomaJia Feng, Longyang Jiang, Hui Tang, et al.
Drug Delivery|August 22, 2025
Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challengesTaimin Luo, Lei Chen, Kun Tu, et al.
Frontiers in Cell and Developmental Biology|December 28, 2020
Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast CancerMing Zhang, Yilin Wang, Yan Wang, et al.
Renal Failure|June 4, 2024
Association between the gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization studyWenjie Dong, Qiuyu Li, Lei Chen, et al.
Pageof 6